|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others. |
| 公司地址
| No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005 |
| 電話號碼
| +86 2034037871 |
| 傳真號碼
| +86 2034037872 |
| 公司網頁
| https://www.brbiotech.com |
| 員工數量
| 674 |
| Ms. Xiaozhi Hu |
Vice President,Finance |
-- |
28/04/2026 |
| Mr. Yusheng Han |
Chairman of the Board and Chief Executive Officer |
-- |
28/04/2026 |
| Dr. Zhihong Zhang |
Director and Chief Technology Officer |
-- |
28/04/2026 |
|
|
| Mr. Feng Deng |
Director |
28/04/2026 |
| Ms. Wendy W. Hayes |
Independent Director |
28/04/2026 |
| Mr. Yusheng Han |
Chairman of the Board and Chief Executive Officer |
28/04/2026 |
| Mr. Gang Lu |
Director |
28/04/2026 |
| Dr. Zhihong Zhang |
Director and Chief Technology Officer |
28/04/2026 |
| Dr. Licen Lisa Xu |
Independent Director |
28/04/2026 |
|
|
|
|
